As part of an interview series Matt Hyde, Director of Recruit121 and FinTech Awards Wales, talks to a whole host of ...
From its base at the Milner Therapeutics Institute, TRIMTECH is developing a pipeline of potent, CNS (central nervous system) ...
Additional investors also include Eli Lilly and Company, MP Healthcare Venture Management (MPH), Cambridge Enterprise Ventures, and Start Codon. The investment will support further development of ...
News Medical on MSN17d
TRIMTECH Therapeutics raises $31M seed funding to advance targeted protein degradation pipeline for treatment of neurodegenerative diseasesAdditional investors also include Eli Lilly and Company, MP Healthcare Venture Management (MPH), Cambridge Enterprise Ventures, and Start Codon. The investment will support further development of the ...
Pharmaceutical Technology on MSN18d
Trimtech closes seed fund round to advance CNS therapeutics pipelineTrimtech Therapeutics has closed a seed funding round of $31m (£25m) to advance its pipeline of the central nervous system (CNS)-penetrant therapeutics that are based on Trimtacs, the ...
For DeepTech funder Cambridge Innovation Capital, it’s a case of back to the future after its decision to take venture builder Start Codon under its management. CIC Partner Michael Anstey, who ...
Still, it’s amazing how many people (myself included) manage to mess those orders up ― so, who better to turn to in our hour of need than Codon Bleu ... the well and start combining the ...
The start of a Phase II study is planned for later ... designed to overcome nonsense mutations that cause a premature stop codon. ZKN-013 has promising potential in several rare indications ...
Scientists dive into the genomes of whales, elephants, and other animal giants looking for new weapons in the fight against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback